iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Basis of Presentation (Details)

Basis of Presentation (Details) - USD ($)			1 Months Ended			12 Months Ended
Basis of Presentation (Details) - USD ($)	Jul. 12, 2018	Jun. 26, 2018	Jun. 26, 2018	Jun. 26, 2018	Nov. 30, 2017	Jun. 30, 2019	Jun. 30, 2018	Jun. 20, 2018	Jun. 30, 2017	Jun. 30, 2016
Basis of Presentation [Line Items]
Accumulated deficit						$ (105,821,000)	$ (88,228,000)
Net Cash Used in Operating Activities						(13,975,000)	(13,480,000)
Cash						4,421,000	15,934,000		$ 15,934,000	$ 8,088,000
Stock Issued During Period, Shares, New Issues				4,350,000	2,250,000
Stock Issued During Period, Value, New Issues	$ 1,350,000			$ 16.0	$ 4,500,000	0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest						$ (17,597,000)	$ (16,108,000)
Shares Issued, Price Per Share		$ 0.90	$ 0.90	$ 0.90	$ 2.00
Preferred Stock, Par or Stated Value Per Share		$ 1,000	1,000	$ 1,000				$ 0.001
Convertible Preferred Stock, Shares Issued upon Conversion						2,470,000	100,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized		2,666,666		2,666,666
Contract with Customer, Liability						$ 1,800,000
Contract with Customer, Liability, Revenue Recognized						2,900,000
Proceeds from Contributed Capital						$ 2,459,000	$ 1,093,000
Preferred stock, par value (in dollars per share)		$ 1,000	1,000	$ 1,000				0.001
Eastern Affiliate [Member]
Basis of Presentation [Line Items]
Proceeds from Contributed Capital					$ 2,459,000
Over-Allotment Option [Member]
Basis of Presentation [Line Items]
Proceeds from Issuance of Common Stock	$ 1,350,000
Stock Issued During Period, Shares, New Issues	1,500,000				11,000
Shares Issued, Price Per Share	$ 0.90	0.90	0.90	$ 0.90
Underwritten Public Offering [Member]
Basis of Presentation [Line Items]
Stock Issued During Period, Value, New Issues				$ 16,000,000
Common Stock [Member]
Basis of Presentation [Line Items]
Stock Issued During Period, Shares, New Issues				4,350,000		142,000
Stock Issued During Period, Value, New Issues						$ 1,000
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest						$ 0	$ 0
Shares Issued, Price Per Share		$ 0.90	$ 0.90	$ 0.90
Convertible Preferred Stock, Shares Issued upon Conversion						2,470,000	100,000
Series A Preferred Stock [Member]
Basis of Presentation [Line Items]
Stock Issued During Period, Shares, New Issues		6,300	6,300	6,300
Preferred Stock, Par or Stated Value Per Share		$ 1,000	$ 1,000	$ 1,000				0.001
Preferred stock, par value (in dollars per share)		$ 1,000	$ 1,000	$ 1,000				$ 0.001
Series A Preferred Stock [Member] \| Common Stock [Member]
Basis of Presentation [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion		7,000,000	7,000,000	7,000,000
Convertible Preferred Stock Conversion Price		$ 0.90	$ 0.90	$ 0.90
Series B Preferred Stock [Member]
Basis of Presentation [Line Items]
Stock Issued During Period, Shares, New Issues		5,785		5,785
Preferred Stock, Par or Stated Value Per Share		$ 1,000	1,000	$ 1,000
Preferred stock, par value (in dollars per share)		$ 1,000	$ 1,000	$ 1,000
Series B Preferred Stock [Member] \| Common Stock [Member]
Basis of Presentation [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion		6,427,778	6,427,778	6,427,778
Convertible Preferred Stock Conversion Price		$ 0.90	$ 0.90	$ 0.90